These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19114345)

  • 21. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis.
    Fung J; Lai CL; Fong DY; Yuen JC; Wong DK; Yuen MF
    Liver Int; 2008 Dec; 28(10):1408-16. PubMed ID: 18482268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stepwise application of fibrosis index based on four factors, red cell distribution width-platelet ratio, and aspartate aminotransferase-platelet ratio for compensated hepatitis B fibrosis detection.
    Chen YP; Hu XM; Liang XE; Huang LW; Zhu YF; Hou JL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):256-263. PubMed ID: 28452125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noninvasive Assessment of Liver Fibrosis Stage Using Ultrasound-Based Shear Wave Velocity Measurements and Serum Algorithms in Patients With Viral Hepatitis B: A Retrospective Cohort Study.
    Liu J; Zhao J; Zhang Y; Ji Y; Lin S; Dun G; Guo S
    J Ultrasound Med; 2017 Feb; 36(2):285-293. PubMed ID: 28039877
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B.
    Lin CL; Liu CH; Wang CC; Liang CC; Su TH; Liu CJ; Kao JH
    J Clin Gastroenterol; 2015 Sep; 49(8):705-13. PubMed ID: 25319739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Routine indexes for cirrhosis and significant fibrosis detection in patients with compensated chronic hepatitis B.
    Zhang ZQ; Huang LW; Chen YP; Wang P
    Dig Liver Dis; 2019 Jan; 51(1):127-134. PubMed ID: 30076017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
    Kim WR; Berg T; Asselah T; Flisiak R; Fung S; Gordon SC; Janssen HL; Lampertico P; Lau D; Bornstein JD; Schall RE; Dinh P; Yee LJ; Martins EB; Lim SG; Loomba R; Petersen J; Buti M; Marcellin P
    J Hepatol; 2016 Apr; 64(4):773-80. PubMed ID: 26626497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Value of non-invasive models of liver fibrosis in judgment of treatment timing in chronic hepatitis B patients with ALT < 2×upper limit of normal].
    Zhou QQ; Hu YB; Zhou K; Zhang WW; Li MH; Dong P; Di JG; Hong L; Du QW; Xie Y; Sun QF
    Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):665-670. PubMed ID: 27788722
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of elastography combined with serological indexes for hepatic fibrosis in patients with chronic hepatitis B.
    Xu B; Zhou NM; Cao WT; Li XJ
    World J Gastroenterol; 2018 Oct; 24(37):4272-4280. PubMed ID: 30310260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
    Islam S; Antonsson L; Westin J; Lagging M
    Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fibro-Mark: a panel of laboratory parameters for predicting significant fibrosis in chronic hepatitis C patients.
    Attallah AM; Omran D; Omran MM; Albannan MS; Zayed RA; Saif S; Farid A; Hassany M; Yosry A
    Br J Biomed Sci; 2018 Jan; 75(1):19-23. PubMed ID: 28945150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of non-invasive models for liver fibrosis in chronic hepatitis B virus related liver disease patients in resource limited settings.
    Shrivastava R; Sen S; Banerji D; Praharaj AK; Chopra GS; Gill SS
    Indian J Pathol Microbiol; 2013; 56(3):196-9. PubMed ID: 24152493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aspartate aminotransferase to platelet ratio index - a reliable predictor of therapeutic efficacy and improvement of Ishak score in chronic hepatitis B patients treated with nucleoside analogues.
    Peng J; Cai S; Yu T; Chen Y; Zhu Y; Sun J
    Scand J Clin Lab Invest; 2016; 76(2):133-42. PubMed ID: 26878877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients.
    Kim BK; Kim DY; Park JY; Ahn SH; Chon CY; Kim JK; Paik YH; Lee KS; Park YN; Han KH
    Liver Int; 2010 Apr; 30(4):546-53. PubMed ID: 20074094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AST-platelet ratio index in the prediction of significant fibrosis and cirrhosis in patients with chronic hepatitis B.
    Güzelbulut F; Sezıklı M; Akkan-Çetınkaya Z; Yaşar B; Özkara S; Kurdaş-Övünç AO
    Turk J Gastroenterol; 2012 Aug; 23(4):353-8. PubMed ID: 22965506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A noninvasive model to predict histological liver cirrhosis in patients with chronic hepatitis B].
    Tu XL; Xiao YQ; Chen F
    Zhonghua Gan Zang Bing Za Zhi; 2009 Jan; 17(1):28-32. PubMed ID: 19203448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.
    Borroni G; Ceriani R; Cazzaniga M; Tommasini M; Roncalli M; Maltempo C; Felline C; Salerno F
    Aliment Pharmacol Ther; 2006 Sep; 24(5):797-804. PubMed ID: 16918883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
    Deghady A; Abdou A; El-Neanaey WA; Diab I
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):531-5. PubMed ID: 22352690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
    Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
    World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.